Ciprofloxacin Tablet
NDC Package 23070-8513-9
Package Information
Ciprofloxacin tablets is a medication used to treat a variety of bacterial infections. This formulation utilizes a tablet delivery system. Marketed by Bayer Healthcare Manufacturing Srl, this product is identified by NDC 23070-8513.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 23070 - Bayer Healthcare Manufacturing Srl
- 23070-8513 -
- 23070-8513-9 - 83486 TABLET in 1 CONTAINER
- 23070-8513 -
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 23070-8513-9 identifies a specific commercial package of 83486 tablet in 1 container of Ciprofloxacin (UNFINISHED drug), drug for further processing labeled by Bayer Healthcare Manufacturing Srl. This tablet is formulated for use and contains ciprofloxacin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bayer Healthcare Manufacturing Srl on July 09, 2024. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat a variety of bacterial infections. Ciprofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for virus infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.
How is this Bayer Healthcare Manufacturing Srl product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 23070851309. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.